Treatment of rat brain membranes with taurine increases radioligand binding.
Green
P
P
Department of Pharmacodynamics, University of Florida, Gainesville 32610, USA.
Dawson
R
R
Wallace
D R
DR
Owens
J
J
D000316:Adrenergic alpha-Agonists / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D000975:Antioxidants / Q000378:metabolism* / Q000494:pharmacology; D002540:Cerebral Cortex / Q000378:metabolism*; D003000:Clonidine / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology; D016291:Dizocilpine Maleate / Q000378:metabolism / Q000494:pharmacology; D018491:Dopamine Agonists / Q000378:metabolism / Q000494:pharmacology; D018691:Excitatory Amino Acid Antagonists / Q000378:metabolism / Q000494:pharmacology; D005260:Female; D008297:Male; D011869:Radioligand Assay; D051381:Rats; D017207:Rats, Sprague-Dawley; D013654:Taurine / Q000378:metabolism* / Q000494:pharmacology; D013764:Tetrahydronaphthalenes / Q000378:metabolism / Q000494:pharmacology
D000316:Adrenergic alpha-Agonists; D000975:Antioxidants; D018491:Dopamine Agonists; D018691:Excitatory Amino Acid Antagonists; D013764:Tetrahydronaphthalenes; D013654:Taurine; D016291:Dizocilpine Maleate; C016986:apraclonidine; D003000:Clonidine; C031349:7-hydroxy-2-N,N-dipropylaminotetralin